Target type: biologicalprocess
The chemical reactions and pathways resulting in the breakdown of histone messenger RNA (mRNA). [GOC:dgf, GOC:krc, PMID:17179095, PMID:17855393]
Histone mRNA catabolic process is a tightly regulated process that ensures the rapid degradation of histone mRNAs in response to cellular demands. This process is crucial for maintaining proper chromatin structure and gene expression. Here's a detailed breakdown:
**1. Initiation:**
* Histone mRNAs are typically transcribed in large quantities during the S phase of the cell cycle, when DNA replication occurs.
* The transcription of histone genes is regulated by a variety of factors, including the availability of transcription factors and the presence of specific DNA elements.
**2. Processing and Translation:**
* Histone mRNAs undergo limited processing, including capping and polyadenylation. This is unlike most other mRNAs, which undergo extensive splicing and other modifications.
* They are translated into histone proteins, which are critical components of nucleosomes, the fundamental building blocks of chromatin.
**3. Rapid Degradation:**
* Histone mRNAs have a very short half-life, typically only a few minutes. This rapid degradation is essential for maintaining proper histone levels and preventing excessive accumulation of histones.
* The degradation of histone mRNAs is initiated by the recruitment of a specific deadenylation complex, which removes the poly(A) tail from the 3' end of the mRNA.
* Following deadenylation, the mRNA is rapidly degraded by a complex of enzymes, including the exosome and the 5'-3' exonuclease Xrn1.
* This process ensures that histone mRNA levels are tightly controlled and that there is a rapid response to changes in cellular demands for histones.
**4. Regulation:**
* The degradation of histone mRNAs is regulated by a variety of factors, including the availability of transcription factors, the presence of specific DNA elements, and the cellular environment.
* For instance, during periods of cell growth and proliferation, histone mRNA degradation is suppressed to allow for the production of large amounts of histones.
* Conversely, during cell cycle arrest or differentiation, histone mRNA degradation is increased to reduce histone levels.
**5. Significance:**
* The histone mRNA catabolic process plays a crucial role in maintaining genome integrity, regulating gene expression, and controlling cell growth and proliferation.
* Disruptions in this process can lead to various cellular abnormalities, including cancer and developmental defects.
**Key Enzymes and Factors Involved:**
* Deadenylation Complex
* Exosome
* Xrn1
* Histone mRNA-specific factors (e.g., SLBP, CAF-1)
**Overall, the histone mRNA catabolic process is a finely tuned mechanism that ensures proper histone levels and contributes to the stability and regulation of the genome.**'
"
Protein | Definition | Taxonomy |
---|---|---|
Serine-protein kinase ATM | A serine-protein kinase ATM that is encoded in the genome of human. [PRO:CNA] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
pd 173074 | aromatic amine; biaryl; dimethoxybenzene; pyridopyrimidine; tertiary amino compound; ureas | antineoplastic agent; EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor; fibroblast growth factor receptor antagonist | |
caffeine | purine alkaloid; trimethylxanthine | adenosine A2A receptor antagonist; adenosine receptor antagonist; adjuvant; central nervous system stimulant; diuretic; EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor; EC 3.1.4.* (phosphoric diester hydrolase) inhibitor; environmental contaminant; food additive; fungal metabolite; geroprotector; human blood serum metabolite; mouse metabolite; mutagen; plant metabolite; psychotropic drug; ryanodine receptor agonist; xenobiotic | |
2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one: specific inhibitor of phosphatidylinositol 3-kinase; structure in first source | chromones; morpholines; organochlorine compound | autophagy inhibitor; EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor; geroprotector |
schizandrin b | schizandrin B: a phytogenic antineoplastic agent with anti-inflammatory activity; isolated from Schisandra plant | ||
thiourea | thiourea : The simplest member of the thiourea class, consisting of urea with the oxygen atom substituted by sulfur. Thiourea: A photographic fixative used also in the manufacture of resins. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance may reasonably be anticipated to be a carcinogen (Merck Index, 9th ed). Many of its derivatives are ANTITHYROID AGENTS and/or FREE RADICAL SCAVENGERS. | one-carbon compound; thioureas; ureas | antioxidant; chromophore |
ku 55933 | 2-morpholin-4-yl-6-thianthren-1-yl-pyran-4-one: specific inhibitor of the ataxia-telangiectasia mutated kinase ATM; structure in first source | ||
cgk 733 | diarylmethane | ||
nu 7026 | 2-(morpholin-4-yl)benzo(h)chromen-4-one: a radiosensitizing agent that inhibits DNA-dependent protein kinase; structure in first source | organic heterotricyclic compound; organooxygen compound | |
nu 7441 | 8-dibenzothiophen-4-yl-2-morpholin-4-yl-chromen-4-one: structure in first source | dibenzothiophenes | |
ku-0060648 | dibenzothiophenes | ||
dactolisib | dactolisib : An imidazoquinoline that is 3-methyl-2-oxo-2,3-dihydro-1H-imidazo[4,5-c]quinoline substituted at position 1 by a 4-(1-cyanoisopropyl)phenyl group and at position 8 by a quinolin-3-yl group. A dual PI3K/mTOR inhibitor used in cancer treatment. dactolisib: antineoplastic agent that inhibits both phosphatidylinositol 3-kinase and mTOR | imidazoquinoline; nitrile; quinolines; ring assembly; ureas | antineoplastic agent; EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor; mTOR inhibitor |
ku 60019 | |||
cp 466722 | quinazolines | ||
(3R)-4-[2-(1H-indol-4-yl)-6-(1-methylsulfonylcyclopropyl)-4-pyrimidinyl]-3-methylmorpholine | indoles | ||
ve 821 | 3-amino-6-(4-(methylsulfonyl)phenyl)-N-phenylpyrazine-2-carboxamide: an antineoplastic agent; structure in first source | aromatic amide | |
torin 2 | torin 2 : A member of the class of pyridoquinolines that is benzo[h][1,6]naphthyridin-2-one carrying additional 3-(trifluoromethyl)phenyl and 6-aminopyridin-3-yl substituents at positions 1 and 9 respectively. It is a potent inhibitor of mTOR and exhibits anti-cancer properties. | aminopyridine; organofluorine compound; primary amino compound; pyridoquinoline | antineoplastic agent; mTOR inhibitor |
byl719 | proline derivative | ||
cc-115 | 1-ethyl-7-(2-methyl-6-(1H-1,2,4-triazol-3-yl)pyridin-3-yl)-3,4-dihydropyrazino(2,3-b)pyrazin-2(1H)-one: an mTOR kinase inhibitor; structure in first source | ||
vx-970 | berzosertib: an ATR kinase inhibitor | sulfonamide | |
etp-46464 | ETP-46464: inhibits ATM and Rad3-related kinase; structure in first source |